In January-June 2025, pharmaceutical manufacturer PJSC Monfarm (Cherkasy region) increased its net profit eightfold compared to the same period in 2024, to UAH 7.3 million.
According to the company’s disclosure to the National Securities and Stock Market Commission (NSSMC), net sales revenue for this period increased by 24.5% to UAH 133.89 million.
Monfarm PJSC was established in 1994 through the corporatization and privatization of the Monastyryshchensky Pharmaceutical Plant, a state-owned enterprise organized in 1986 on the basis of a distillery that was part of the Darnitsa Pharmaceutical Association in Kyiv.
Monfarm specializes in the production of suppositories and tableted drugs, with more than 70 names of drugs from various pharmaceutical groups.
The quality of products is confirmed by GMP certificates.
